7203US Cardiolipin-A (FDA cleared)

Intended Use:

AESKULISA Cardiolipin-A is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgA antibodies against cardiolipin in human serum.

Recombinant Antigens:

n.a.

Native Antigens:

ß2-Glycoprotein I, Cardiolipin

Kit Configuration

Type: AESKULISA®
Method: Elisa
Reference: 7203US
Description: Cardiolipin-A (FDA cleared)
Kit Configuration: Single - A
Cut Off: 15
Range: 0 - 300 U/ml
Standard: Harris
Antibodies: IgA

Downloads